TRIM38 triggers the ubiquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

(2020) Thomas W. Flaig et al.   Journal of the National Comprehensive Cancer Network

Traditional Classification and Novel Subtyping Systems for Bladder Cancer

(2020) Shaoming Zhu et al.   Frontiers in Oncology

KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC

(2020) Ashish M Kamat et al.   Future Oncology

Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy

(2020) Maëlle Cartel et al.   LEUKEMIA

Treatment of muscle‐invasive and advanced bladder cancer in 2020

(2020) Vaibhav G. Patel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers

(2020) Jun Wang et al.   CANCER LETTERS

Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer

(2020) Elisabeth Smolle et al.   Molecular Oncology

Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence

(2020) Siamak Daneshmand et al.   European Urology Focus

Hypoxia induces the translocation of glucose transporter 1 to the plasma membrane in vascular endothelial cells

(2020) Abdullah Al Mamun et al.   Journal of Physiological Sciences

Bladder Cancer

(2020) Andrew T. Lenis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Examining the Accuracy of Self-Reported Smoking-Related Exposure Among Recently Diagnosed Non-muscle Invasive Bladder Cancer Patients.

(2020) Stacey Petruzella et al.   JOURNAL OF UROLOGY

RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target

(2020) Huarong Chen et al.   GASTROENTEROLOGY

SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake

(2019) Jia Chen et al.   Human Cell

The Natural History of Untreated Muscle Invasive Bladder Cancer

(2019) Alberto Martini et al.   BJU INTERNATIONAL

Epigenetic Compensation Promotes Liver Regeneration

(2019) Shuang Wang et al.   DEVELOPMENTAL CELL

Molecular and histopathology directed therapy for advanced bladder cancer

(2019) Constantine Alifrangis et al.   Nature Reviews Urology

Secular trends in incidence and mortality of bladder cancer in China, 1990–2017: A joinpoint and age-period-cohort analysis

(2019) Xiaoxue Liu et al.   Cancer Epidemiology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

(2019) Marko Babjuk et al.   EUROPEAN UROLOGY

Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis

(2019) Sarah M. Wade et al.   EBioMedicine

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer

(2019) Ryan L. Steinberg et al.   JOURNAL OF UROLOGY

Targeting deubiquitinase USP28 for cancer therapy

(2018) Xiaofang Wang et al.   Cell Death & Disease

Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation

(2018) Yun-Xin Lu et al.   Theranostics

Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer

(2018) Subhamoy Dasgupta et al.   NATURE

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Proteasome inhibitors in cancer therapy

(2017) Elisabet E. Manasanch et al.   Nature Reviews Clinical Oncology

Landmarks in the treatment of muscle-invasive bladder cancer

(2017) Niyati Lobo et al.   Nature Reviews Urology

The Emerging Hallmarks of Cancer Metabolism

(2016) Natalya N. Pavlova et al.   Cell Metabolism

Metabolic Reprogramming of Stem Cell Epigenetics

(2015) James G. Ryall et al.   Cell Stem Cell

TRIM38 Negatively Regulates TLR3/4-Mediated Innate Immune and Inflammatory Responses by Two Sequential and Distinct Mechanisms

(2015) Ming-Ming Hu et al.   JOURNAL OF IMMUNOLOGY

Metabolic Reprogramming of Macrophages

(2014) Alex J. Freemerman et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Ubiquitination in disease pathogenesis and treatment

(2014) Doris Popovic et al.   NATURE MEDICINE

TRIM38 inhibits TNF - and IL-1 -triggered NF- B activation by mediating lysosome-dependent degradation of TAB2/3

(2014) M.-M. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality

(2011) D. A. Chan et al.   Science Translational Medicine